Growth Metrics

Armata Pharmaceuticals (ARMP) Change in Accured Expenses (2016 - 2026)

Quarterly results put Change in Accured Expenses at -$352000.0 for Q1 2026, up 36.35% from a year ago — trailing twelve months through Mar 2026 was $112000.0 (up 102.5% YoY), and the annual figure for FY2025 was -$89000.0, up 97.63%.

Armata Pharmaceuticals has reported Change in Accured Expenses over the past 14 years, most recently at -$352000.0 for Q1 2026.

  • Change in Accured Expenses reached -$352000.0 in Q1 2026 per ARMP's latest filing, down from $348000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.9 million in Q4 2022 and bottomed at -$2.3 million in Q2 2024.
  • Median Change in Accured Expenses over the past 5 years was -$265000.0 (2025), compared with a mean of -$93588.2.
  • The largest annual shift saw Change in Accured Expenses surged 420.06% in 2023 before it plummeted 407.22% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $2.9 million in 2022, then plummeted by 125.53% to -$739000.0 in 2023, then tumbled by 133.29% to -$1.7 million in 2024, then surged by 120.19% to $348000.0 in 2025, then crashed by 201.15% to -$352000.0 in 2026.
  • Business Quant data shows Change in Accured Expenses for ARMP at -$352000.0 in Q1 2026, $348000.0 in Q4 2025, and $381000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 931,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 70.50 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 107.70 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -176.03 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -352,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -352,000.00
Mar 31, 2026 -352,000.00
Dec 31, 2025 348,000.00
Dec 31, 2025 348,000.00
Sep 30, 2025 381,000.00
Sep 30, 2025 381,000.00
Jun 30, 2025 -265,000.00
Jun 30, 2025 -265,000.00
Mar 31, 2025 -553,000.00
Mar 31, 2025 -553,000.00
Dec 31, 2024 -1.72 Mn
Dec 31, 2024 -1.72 Mn
Sep 30, 2024 111,000.00
Sep 30, 2024 111,000.00
Jun 30, 2024 -2.32 Mn
Jun 30, 2024 -2.32 Mn
Mar 31, 2024 180,000.00
Mar 31, 2024 180,000.00
Dec 31, 2023 -739,000.00
Dec 31, 2023 -739,000.00
Sep 30, 2023 -437,000.00
Sep 30, 2023 -437,000.00
Jun 30, 2023 1.02 Mn
Jun 30, 2023 1.02 Mn
Mar 31, 2023 -905,000.00
Mar 31, 2023 -905,000.00
Dec 31, 2022 2.90 Mn
Dec 31, 2022 2.90 Mn
Sep 30, 2022 149,000.00
Sep 30, 2022 149,000.00
Jun 30, 2022 -319,000.00
Jun 30, 2022 -319,000.00
Mar 31, 2022 940,000.00
Mar 31, 2022 940,000.00
Dec 31, 2021 -967,000.00
Dec 31, 2021 -967,000.00
Sep 30, 2021 1.05 Mn
Sep 30, 2021 1.05 Mn
Jun 30, 2021 509,000.00
Jun 30, 2021 509,000.00
Mar 31, 2021 -409,000.00
Mar 31, 2021 -409,000.00
Dec 31, 2020 -1.25 Mn
Dec 31, 2020 -1.25 Mn
Sep 30, 2020 258,000.00
Sep 30, 2020 258,000.00
Jun 30, 2020 429,000.00
Jun 30, 2020 429,000.00
Mar 31, 2020 -195,000.00
Mar 31, 2020 -195,000.00
Dec 31, 2019 -765,000.00
Dec 31, 2019 -765,000.00
Sep 30, 2019 -258,000.00
Sep 30, 2019 -258,000.00
Jun 30, 2019 -780,000.00
Jun 30, 2019 -780,000.00
Mar 31, 2019 429,000.00
Mar 31, 2019 429,000.00
Dec 31, 2018 -371,000.00
Dec 31, 2018 -371,000.00
Sep 30, 2018 648,000.00
Sep 30, 2018 648,000.00
Jun 30, 2018 222,000.00
Jun 30, 2018 222,000.00
Mar 31, 2018 -355,000.00
Mar 31, 2018 -355,000.00
Dec 31, 2017 -243,000.00
Dec 31, 2017 -243,000.00
Sep 30, 2017 -583,000.00
Sep 30, 2017 -583,000.00
Jun 30, 2017 519,000.00
Jun 30, 2017 519,000.00
Mar 31, 2017 -531,000.00
Mar 31, 2017 -531,000.00
Dec 31, 2016 190,000.00
Dec 31, 2016 190,000.00
Sep 30, 2016 388,000.00
Sep 30, 2016 388,000.00
Jun 30, 2016 -679,000.00
Jun 30, 2016 -679,000.00